Lumos Diagnostics Holdings Limited (ASX:LDX)
0.1800
+0.0150 (9.09%)
Sep 15, 2025, 4:20 PM AEST
ASX:LDX Revenue
In the fiscal year ending June 30, 2025, Lumos Diagnostics Holdings had annual revenue of $12.40M USD with 11.40% growth. Lumos Diagnostics Holdings had revenue of $6.09M in the half year ending June 30, 2025, with 11.86% growth.
Revenue
$12.40M
Revenue Growth
+11.40%
P/S Ratio
7.38
Revenue / Employee
n/a
Employees
n/a
Market Cap
139.62M AUD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 12.40M | 1.27M | 11.40% |
Jun 30, 2024 | 11.13M | 596.00K | 5.66% |
Jun 30, 2023 | 10.54M | -1.10M | -9.42% |
Jun 30, 2022 | 11.63M | -7.22M | -38.32% |
Jun 30, 2021 | 18.85M | 13.06M | 225.25% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 23.73B |
Pro Medicus | 212.98M |
Cochlear | 2.34B |
Sonic Healthcare | 9.65B |
Ramsay Health Care | 17.79B |
Ansell | 3.06B |
Telix Pharmaceuticals | 1.01B |
Mesoblast | 26.23M |